Cormedix (NASDAQ:CRMD) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.36 by 16.22 percent. This is a 43.33 percent increase over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $127.427 million which beat the analyst consensus estimate of $105.017 million by 21.34 percent. This is a 226.07 percent increase over sales of $39.080 million the same period last year.